SABBY MANAGEMENT LLC
Q2 2026 Form 13-F
SPICEWOOD, TEXAS
CIK 0001535610
· CRD 162659
· Exempt reporting adviser
Consolidated report · includes
1 manager
since Q3 2024
$110.5M Reported Value Total
Exempt Reporting Adviser
Discretionary Manager
Private funds (Form ADV)
2 funds
· $197.4M gross asset value
Private Equity Fund: $181.5M · Hedge Fund: $15.8M
Source: Form ADV filed 2026-07-08
Reported value
$110.5M
Quarter over quarter
+8.6%
Holdings
16
Top-10 concentration
96.9%
Filing Structure
Reports holdings for
- Hal Mintz (not a 13F filer in our records) · since Q3 2024 · declared by one filing
- Mintz Hal · File #028-13502 · Q2 2013 – Q1 2025 · declared by one filing
Key People
Form ADV owners & control persons
Hal David Mintz
PRINCIPAL AND MANAGING MEMBER OF SABBY MANAGEMENT, LLC AND SABBY CAPITAL, LLC
Robert Alan Grundstein
CHIEF COMPLIANCE OFFICER OF SABBY MANAGEMENT, LLC AND SABBY CAPITAL, LLC
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q2 2026 13F record
Q2 2026 13F filing summary
| Period of report | June 30, 2026 |
|---|---|
| Filed | August 14, 2026 |
| Form | 13F-HR |
| Reported value | $110.5M |
| Positions | 16 |
| Change in reported value | +145.2% |
| New positions | 8 |
| Exited positions | 14 |
| Position turnover | 73.3% |
| Top-10 concentration | 96.9% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 14, 2026
|
16 | $110.5M |
|
Q1 2026 13F
Filed May 15, 2026
|
22 | $45.1M |
|
Q4 2025 13F
Filed Feb 17, 2026
|
25 | $69.5M |
|
Q3 2025 13F
Filed Nov 14, 2025
|
29 | $86.4M |
|
Q2 2025 13F
Filed Aug 14, 2025
|
33 | $55.1M |
|
Q1 2025 13F
Filed May 15, 2025
|
36 | $34.0M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
16 | $76.9M |
|
Q3 2024 13F
Filed Nov 14, 2024
|
27 | $186.4M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
27 | $148.7M |
|
Q1 2024 13F
Filed May 15, 2024
|
43 | $173.3M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
46 | $100.0M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
66 | $136.6M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
68 | $122.2M |
|
Q1 2023 13F
Filed May 15, 2023
|
72 | $114.8M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
89 | $114.0M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
82 | $79.3M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
75 | $147.0M |
|
Q1 2022 13F
Filed May 16, 2022
|
83 | $669.7M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
103 | $687.8M |
|
Q3 2021 13F
Filed Nov 15, 2021
|
93 | $739.9M |
33 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q2 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | SPY P STATE STREET SPDR S&P | $54.1M | 48.99% |
| 2 | SPY C STATE STREET SPDR S&P | $15.3M | 13.85% |
| 3 | NYC C ISHARES RUSSELL | $13.3M | 12.02% |
| 4 | NYC P ISHARES RUSSELL | $13.2M | 11.99% |
| 5 | SPY STATE STREET SPDR S&P | $4.1M | 3.72% |
| 6 | TOYO TOYO CO LTD | $3.5M | 3.17% |
| 7 | ABVX C ABIVAX SA | $1.1M | 0.99% |
| 8 | FAMI FARMMI INC | $840.3K | 0.76% |
| 9 | SIDU P SIDUS SPACE INC | $816.3K | 0.74% |
| 10 | CRVO CERVOMED INC | $771.5K | 0.7% |
| 11 | ZVRA P ZEVRA THERAPEUTICS | $612.3K | 0.55% |
| 12 | TPST TEMPEST THERAPEUTICS INC | $567.5K | 0.51% |
| 13 | PAVS PARANOVUS ENTERTNMNT TECH LT | $560.5K | 0.51% |
| 14 | BIAF BIOAFFINITY TECHNOLOGIES | $296.9K | 0.27% |
| 15 | CREG SMART POWER CORP | $263.2K | 0.24% |
| 16 | BCTX BRIACELL THERAPEUTICS CORP | $261.5K | 0.24% |
| 17 | REVB REVELATION BIOSCIENCES INC | $216.9K | 0.2% |
| 18 | SNES SENESTECH INC | $211.2K | 0.19% |
| 19 | BCTXL BRIACELL THERAPEUTICS CORP | $169.4K | 0.15% |
| 20 | SIDU SIDUS SPACE INC | $121.9K | 0.11% |
Values as reported on the Q2 2026 Form 13F. Every position is in the holdings table below.